NCT02404675 2017-07-28
INCREASE
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
Clinical Trials
7 trialsNCT02778893 2016-05-20
Conmana Combined With Thalidomide to Treat NSCLC
Henan Provincial People's Hospital
Phase 4 Unknown
NCT02031601 2016-03-29
TCL-1
Qilu Hospital of Shandong University
Phase 4 Unknown
NCT01646450 2015-09-09
First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01926171 2015-07-15
Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02283424 2014-11-05
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Phase 4 Unknown